The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.
Study Type
OBSERVATIONAL
Enrollment
50
Avera Research Institute
Sioux Falls, South Dakota, United States
Genetic polymorphisms of insulin-like growth factors
This study consists of a single clinic visit. After subject has completed the informed consent process and meets eligibility criteria, a blood sample and a saliva sample will be collected. Genetic results from this one-time specimen collection will be evaluated and compared with results from participants in the other two study groups. Outcomes will be measured comparatively.
Time frame: Single clinic visit (day 1)
Genetic testing of Apolipoprotein (APO) E4
This study consists of a single clinic visit. After subject has completed the informed consent process and meets eligibility criteria, a blood sample and a saliva sample will be collected. Genetic results from this one-time specimen collection will be evaluated and compared with results from participants in the other two study groups. Outcomes will be measured comparatively.
Time frame: Single clinic visit (day 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.